Victory Capital Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Victory Capital Management’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-24,334	Closed	-$28K	–	2846
2022 Q2	$28K	Buy	24,334 +531	+2%	+$555	﹤0.01%	2594
2022 Q1	$28K	Buy	23,803 +867	+4%	+$655	﹤0.01%	2629
2021 Q4	$17K	Sell	22,936 -597	-3%	-$483	﹤0.01%	2701
2021 Q3	$21K	Sell	23,533 -499	-2%	-$601	﹤0.01%	2729
2021 Q2	$40K	Buy	24,032 +1,185	+5%	+$1.98K	﹤0.01%	2682
2021 Q1	$48K	Buy	22,847 +1,390	+6%	+$2.89K	﹤0.01%	2669
2020 Q4	$27K	Buy	21,457 +1,748	+9%	+$2.09K	﹤0.01%	2492
2020 Q3	$24K	Sell	19,709 -1,354	-6%	-$1.65K	﹤0.01%	2429
2020 Q2	$25K	Sell	21,063 -12,675	-38%	-$11.7K	﹤0.01%	2439
2020 Q1	$28K	Buy	+33,738	New	+$35.8K	﹤0.01%	2995
2019 Q4	–	Sell	-14,555	Closed	-$21K	–	3542
2019 Q3	$21K	Buy	+14,555	New	+$20.6K	﹤0.01%	3031

Victory Capital Management's MBII Position: Q3 2022 in Review

Victory Capital Management sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 24,334 shares — an estimated $28K sold.

Victory Capital Management first reported a position in MBII in Q3 2019 and held it in 11 quarters. The position peaked at $48K in Q1 2021. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.

Victory Capital Management reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
Victory Capital Management sold 24,334 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $28K.
Victory Capital Management first reported a position in Marrone Bio Innovations, Inc. in Q3 2019 and held it in 11 quarters.
Victory Capital Management's Marrone Bio Innovations, Inc. position peaked at $48K in Q1 2021.
0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.

Based on Victory Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.